Roumyana Spassova
Nurse Practitioner · Winston Salem, NCNPI 1588914337
Payments from drug & device makers
Across 289 payments — averaging $27.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Cequr Corporation$951
- Novo Nordisk$854
- Insulet Corporation$805
- Lilly USA, LLC$588
- Corcept Therapeutics$533
- plus $3K from 22 others
What the payments were for
- Food & beverage$7,87499%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 29 | $1,038 |
| Cequr Corporation | 2 | $951 |
| Novo Nordisk | 54 | $854 |
| Insulet Corporation | 27 | $805 |
| Lilly USA, LLC | 24 | $588 |
| Corcept Therapeutics | 13 | $533 |
| Dexcom, Inc. | 19 | $480 |
| AstraZeneca | 12 | $424 |
| Sanofi-aventis U.S. LLC | 11 | $346 |
| Amgen | 22 | $325 |
| Bayer | 16 | $305 |
| AbbVie | 13 | $230 |
| Abbott | 6 | $189 |
| Mannkind Corporation | 5 | $131 |
| BETA Bionics, Inc. | 4 | $108 |
| Boehringer Ingelheim | 6 | $99 |
| Sequel Med Tech, LLC | 3 | $78 |
| Pfizer | 4 | $73 |
| Esperion Therapeutics, Inc. | 3 | $70 |
| GSK | 3 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Boston Scientific | 2 | $45 |
| Shield Therapeutics Inc | 2 | $32 |
| Tolmar, Inc. | 2 | $31 |
| Verity Pharmaceuticals Inc. | 1 | $27 |
| Exact Sciences | 1 | $21 |
| Tandem Diabetes Care, Inc. | 1 | $20 |
| Clarus Therapeutics Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$951
- Omnipod$252
- AIRSUPRA$233
- Korlym$225
- InPen$137
- Minimed 630G$134
- DEXCOM G6 TRANSMITTER$128
- SOLIQUA 100/33$125
- RYBELSUS$120
- FreeStyle Libre Pro$113
- MOUNJARO$108
How this compares
$7,928 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 315 | $435,966 |
| MounjaroTirzepatide | 230 | $294,465 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 95 | $130,463 |
| JardianceEmpagliflozin | 100 | $105,318 |
| FarxigaDapagliflozin Propanediol | 68 | $74,974 |
| Tresiba Flextouch U-200Insulin Degludec | 62 | $69,658 |
| TrulicityDulaglutide | 44 | $61,449 |
| RybelsusSemaglutide | 20 | $37,841 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 27 | $34,042 |
| ProliaDenosumab | 15 | $26,492 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $25,357 |
| NovologInsulin Aspart | 61 | $23,880 |
| Tresiba Flextouch U-100Insulin Degludec | 43 | $23,014 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 15 | $19,285 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $17,538 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $854 | $497,687396 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $588 | $372,717353 claims |
| Boehringer IngelheimJardiance | $99 | $105,318100 claims |
| AstraZenecaFarxiga | $424 | $74,97468 claims |
| AmgenProlia | $325 | $26,49215 claims |
| PfizerEliquis | $73 | $16,32516 claims |
| AbbVieSynthroid | $230 | $4,75943 claims |
| Sanofi-aventis U.S. LLCLantus | $346 | $2,62718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Winston Salem
- Olivia OgburnWinston Salem$70K
- Amy MitchellWinston Salem$33K
- Mary SandsWinston Salem$32K
- Ladonna CookWinston Salem$23K
- Gillian WinterWinston Salem$18K
- Christine ZdebWinston Salem$15K
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
- Jamie DinerDurham$170K
- Ayeshia WrightMocksville$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.